跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
3-Methyladenine
首页
药物
3-Methyladenine
Experimental
Small Molecule
3-Methyladenine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
6
H
7
N
5
CAS 编号
5142-23-4
UNII ID
DR88TV7SNU
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
INITIATING CAPPED OLIGONUCLEOTIDE PRIMERS FOR SYNTHESIZING 5'-CAPPED RNAS
EP 3906789 B2
申请人: TRILINK BIOTECHNOLOGIES LLC
优先权: 2015
CN
EP
7 件公开
Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use Thereof
US 20250250586 A1
申请人: UNIV EAST CHINA NORMAL
优先权: 2021
CN
US
WO
3 件公开
USE OF CELL AUTOPHAGY (TYPE II CELL APOPTOSIS) INHIBITORS
US 2012238566 A1
申请人: JIANG CHENGYU
优先权: 2009
CN
US
2 件公开
Application of 3-methyladenine (3-MA) in preparing medicament for treating atherosclerosis and related diseases thereof
CN 103948601 A
申请人: UNIV SHANDONG
优先权: 2014
CN
Combination treatment of RAS-positive diseases with PDE-δ inhibitor and direct autophagy inhibitor
US 9861623 B1
申请人: UNIV MACAU SCI & TECH
优先权: 2016
US
Application of combination of adenosine and autophagy inhibitor in preparation of drugs for treating colon cancer
CN 109091490 A
申请人: HUASHAN HOSPITAL FUDAN UNIV
优先权: 2018
CN
Application of 3-methyladenine in preparation of medicine for preventing acute pneumonia induced by pseudomonas aeruginosa
CN 113134004 A
申请人: INST MED BIOLOGY CAMS
优先权: 2021
CN
Mesoporous nano-enzyme loaded with autophagy inhibitor and preparation method of mesoporous nano-enzyme
CN 115887681 A
申请人: SHANGHAI INST CERAMICS CAS
优先权: 2021
CN
Novel gene editing system for mediating A-to-C mutation or T-to-G mutation and application thereof
CN 116200382 A
申请人: UNIV EAST CHINA NORMAL
优先权: 2021
CN
Application of 3-methyladenine in preparation of medicine for preventing or treating postoperative tissue adhesion
CN 116919970 A
申请人: UNIV BEIJING
优先权: 2022
CN
第 1 / 2 页
上一页
下一页
药物
反馈